David Collins
David Collins
Потвърден имейл адрес: icr.ac.uk
Diffusion-weighted MRI in the body: applications and challenges in oncology
DM Koh, DJ Collins
American Journal of Roentgenology 188 (6), 1622-1635, 2007
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations
AR Padhani, G Liu, D Mu-Koh, TL Chenevert, HC Thoeny, T Takahara, ...
Neoplasia 11 (2), 102-125, 2009
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ...
Science 359 (6378), 920-926, 2018
Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges
DM Koh, DJ Collins, MR Orton
American Journal of Roentgenology 196 (6), 1351-1361, 2011
Stacked autoencoders for unsupervised feature learning and multiple organ detection in a pilot study using 4D patient data
HC Shin, MR Orton, DJ Collins, SJ Doran, MO Leach
IEEE transactions on pattern analysis and machine intelligence 35 (8), 1930-1943, 2012
Technology insight: water diffusion MRI—a potential new biomarker of response to cancer therapy
DM Patterson, AR Padhani, DJ Collins
Nature clinical practice Oncology 5 (4), 220-233, 2008
Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients
DM Koh, E Scurr, D Collins, B Kanber, A Norman, MO Leach, JE Husband
American Journal of Roentgenology 188 (4), 1001-1008, 2007
Whole-body diffusion-weighted MR imaging in cancer: current status and research directions
AR Padhani, DM Koh, DJ Collins
Radiology 261 (3), 700-718, 2011
Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and …
A Andreou, DM Koh, DJ Collins, M Blackledge, T Wallace, MO Leach, ...
European radiology 23, 428-434, 2013
Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer
MLW Ah-See, A Makris, NJ Taylor, M Harrison, PI Richman, RJ Burcombe, ...
Clinical Cancer Research 14 (20), 6580-6589, 2008
METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based …
AR Padhani, FE Lecouvet, N Tunariu, DM Koh, F De Keyzer, DJ Collins, ...
European urology 71 (1), 81-92, 2017
Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging—value of histogram analysis of apparent diffusion coefficients
S Kyriazi, DJ Collins, C Messiou, K Pennert, RL Davidson, SL Giles, ...
Radiology 261 (1), 182-192, 2011
Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body
DM Koh, T Takahara, Y Imai, DJ Collins
Magnetic Resonance in Medical Sciences 6 (4), 211-224, 2007
Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS)
C Messiou, J Hillengass, S Delorme, FE Lecouvet, LA Moulopoulos, ...
Radiology 291 (1), 5-13, 2019
Computed diffusion-weighted MR imaging may improve tumor detection
MD Blackledge, MO Leach, DJ Collins, DM Koh
Radiology 261 (2), 573-581, 2011
Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma
SL Giles, C Messiou, DJ Collins, VA Morgan, CJ Simpkin, S West, ...
Radiology 271 (3), 785-794, 2014
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies
TA Yap, D Olmos, AT Brunetto, N Tunariu, J Barriuso, R Riisnaes, L Pope, ...
Journal of Clinical Oncology 29 (10), 1271-1279, 2011
Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls
DM Koh, M Blackledge, AR Padhani, T Takahara, TC Kwee, MO Leach, ...
American Journal of Roentgenology 199 (2), 252-262, 2012
Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry—initial observations
PJ Hoskin, DM Carnell, NJ Taylor, RE Smith, JJ Stirling, FM Daley, ...
International Journal of Radiation Oncology* Biology* Physics 68 (4), 1065-1071, 2007
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer
P Nathan, M Zweifel, AR Padhani, DM Koh, M Ng, DJ Collins, A Harris, ...
Clinical Cancer Research 18 (12), 3428-3439, 2012
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20